Trial Details

ACTIVE_NOT_RECRUITING
Basic Information
Clinical ID c910
Identifier NCT03950232
Trial Title An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Etrasimod
Participant Information
Sponsor Pfizer
City Dothan
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2019-09-05
Primary Completion Date 2029-06-19
Completion Date 2029-06-19